Search

Your search for "gbi research arthritis therapeutics market 2018 novel oral jak inhibitors biologic disease" gave back 321289 results.
Decernotinib is a novel, potent, selective and orally available JAK3 inhibitor for the treatment of autoimmune diseases. The “Decernotinib (JAK3...
LPI
February 2023
Price: USD 3,660.00
Decernotinib is a novel, potent, selective and orally available JAK3 inhibitor for the treatment of autoimmune diseases. The global Decernotinib (...
MRRPB5
February 2023
Price: USD 2,900.00
Decernotinib is a novel, potent, selective and orally available JAK3 inhibitor for the treatment of autoimmune diseases. According to our Publisher...
GIR
February 2023
Price: USD 3,480.00
Decernotinib is a novel, potent, selective and orally available JAK3 inhibitor for the treatment of autoimmune diseases. The global Decernotinib (...
MRRPB5
February 2024
Price: USD 2,900.00
Decernotinib is a novel, potent, selective and orally available JAK3 inhibitor for the treatment of autoimmune diseases. The global Decernotinib (...
MRRPB5
July 2023
Price: USD 4,900.00
Pacritinib is an orally bioavailable inhibitor of Janus kinase 2 (JAK2) and the JAK2 mutant JAK2V617F with potential antineoplastic activity. The “...
LPI
February 2023
Price: USD 3,660.00
Pacritinib is an orally bioavailable inhibitor of Janus kinase 2 (JAK2) and the JAK2 mutant JAK2V617F with potential antineoplastic activity. The...
MRRPB5
February 2023
Price: USD 2,900.00
Pacritinib is an orally bioavailable inhibitor of Janus kinase 2 (JAK2) and the JAK2 mutant JAK2V617F with potential antineoplastic activity...
GIR
February 2023
Price: USD 3,480.00
Pacritinib is an orally bioavailable inhibitor of Janus kinase 2 (JAK2) and the JAK2 mutant JAK2V617F with potential antineoplastic activity. The...
MRRPB5
February 2024
Price: USD 2,900.00
Peficitinib(CAS 944118-01-8) is a novel potent JAK inhibitor, which demonstrated potent efficacy in adjuvant-induced arthritis model in rats. The “...
LPI
February 2023
Price: USD 3,660.00
Pacritinib is an orally bioavailable inhibitor of Janus kinase 2 (JAK2) and the JAK2 mutant JAK2V617F with potential antineoplastic activity. The...
MRRPB5
July 2023
Price: USD 4,900.00
Peficitinib(CAS 944118-01-8) is a novel potent JAK inhibitor, which demonstrated potent efficacy in adjuvant-induced arthritis model in rats. The...
MRRPB5
February 2023
Price: USD 2,900.00
Peficitinib(CAS 944118-01-8) is a novel potent JAK inhibitor, which demonstrated potent efficacy in adjuvant-induced arthritis model in rats...
GIR
February 2023
Price: USD 3,480.00
Peficitinib(CAS 944118-01-8) is a novel potent JAK inhibitor, which demonstrated potent efficacy in adjuvant-induced arthritis model in rats. The...
MRRPB5
February 2024
Price: USD 2,900.00
Peficitinib(CAS 944118-01-8) is a novel potent JAK inhibitor, which demonstrated potent efficacy in adjuvant-induced arthritis model in rats. The...
MRRPB5
July 2023
Price: USD 4,900.00

Contact Us for Custom Market Research Solutions

 

Custom Market Research Reports

Filter By Industry

Clients Who Trust Us

Market Research Reports Inc. Customers

Need tailor made market research solution? We can help you with that too.

About Us

At Market Research Reports, Inc. we aim to make it easier for decision makers to find relevant information and locate right market research reports which can save their time and assist in what they do best, i.e. take time-critical decisions.

We work with our associate Global market research firms who are known leaders in their respective domains to obtain right market research solution for our customer’s needs, be it custom research or syndicated research reports.

Contact Us

Market Research Reports, Inc
16192 Coastal Hwy
Lewes
, DE 19958, USA

USA: +1-302-703-9904

India: +91-8762746600

marketresearchreports

info@marketresearchreports.com

User login

Stay Connected